Article Details

Monoclonal Antibody Combination Improves HRQOL in Patients With COVID-19

Retrieved on: 2024-10-15 14:33:43

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal Antibody Combination Improves HRQOL in Patients With COVID-19. View article details on hiswai:

Summary

The article discusses clinical research on the monoclonal antibody combination casirivimab-imdevimab, showing its effectiveness in improving COVID-19 symptoms, patient-reported outcomes, and quality of life, relating to COVID-19 drug development and mind-body interventions.

Article found on: www.hematologyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up